Statin therapy modulates thickness and inflammatory profile of human epicardial adipose tissue
Copyright © 2018 Elsevier B.V. All rights reserved..
BACKGROUND: Epicardial adipose tissue (EAT) thickness and pro-inflammatory status has been shown to be associated with several cardiac diseases, including aortic stenosis (AS). Thus, cardiac visceral fat could represent a potential new target for drugs. In the present study we evaluate the effect of statin therapy on EAT accumulation and inflammation.
METHODS: Echocardiographic EAT thickness was assessed in 193 AS patients taking (n.87) and not taking (n.106) statins, undergoing cardiac surgery. To explore the association between statin therapy and EAT inflammation, EAT biopsies were obtained for cytokines immunoassay determination in EAT secretomes. An in vitro study was also conducted and the modulation of EAT and subcutaneous adipose tissue (SCAT) secretomes by atorvastatin was assessed in paired biopsies.
RESULTS: Statin therapy was significantly associated with lower EAT thickness (p < 0.0001) and with lower levels of EAT-secreted inflammatory mediators (p < 0.0001). Of note, there was a significant correlation between EAT thickness and its pro-inflammatory status. In vitro, atorvastatin showed a direct anti-inflammatory effect on EAT which was significantly higher compared to the SCAT response to statin incubation (p < 0.0001).
CONCLUSIONS: The present study indicates a robust association between statin therapy and reduced EAT accumulation in patients with AS. The present data also suggest a direct relationship between EAT thickness and its inflammatory status, both modulated by statin therapy. The in vitro results support the hypothesis of a direct action of statins on EAT secretory profile. Overall our data suggest EAT as a potential new therapeutic target for statin therapy.
Errataetall: |
CommentIn: Int J Cardiol. 2019 Jan 1;274:353-354. - PMID 30196996 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:274 |
---|---|
Enthalten in: |
International journal of cardiology - 274(2019) vom: 01. Jan., Seite 326-330 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Parisi, Valentina [VerfasserIn] |
---|
Links: |
---|
Themen: |
A0JWA85V8F |
---|
Anmerkungen: |
Date Completed 19.07.2019 Date Revised 19.07.2019 published: Print-Electronic CommentIn: Int J Cardiol. 2019 Jan 1;274:353-354. - PMID 30196996 Citation Status MEDLINE |
---|
doi: |
10.1016/j.ijcard.2018.06.106 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM290864461 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM290864461 | ||
003 | DE-627 | ||
005 | 20231225065635.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ijcard.2018.06.106 |2 doi | |
028 | 5 | 2 | |a pubmed24n0969.xml |
035 | |a (DE-627)NLM290864461 | ||
035 | |a (NLM)30454723 | ||
035 | |a (PII)S0167-5273(18)33054-7 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Parisi, Valentina |e verfasserin |4 aut | |
245 | 1 | 0 | |a Statin therapy modulates thickness and inflammatory profile of human epicardial adipose tissue |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 19.07.2019 | ||
500 | |a Date Revised 19.07.2019 | ||
500 | |a published: Print-Electronic | ||
500 | |a CommentIn: Int J Cardiol. 2019 Jan 1;274:353-354. - PMID 30196996 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2018 Elsevier B.V. All rights reserved. | ||
520 | |a BACKGROUND: Epicardial adipose tissue (EAT) thickness and pro-inflammatory status has been shown to be associated with several cardiac diseases, including aortic stenosis (AS). Thus, cardiac visceral fat could represent a potential new target for drugs. In the present study we evaluate the effect of statin therapy on EAT accumulation and inflammation | ||
520 | |a METHODS: Echocardiographic EAT thickness was assessed in 193 AS patients taking (n.87) and not taking (n.106) statins, undergoing cardiac surgery. To explore the association between statin therapy and EAT inflammation, EAT biopsies were obtained for cytokines immunoassay determination in EAT secretomes. An in vitro study was also conducted and the modulation of EAT and subcutaneous adipose tissue (SCAT) secretomes by atorvastatin was assessed in paired biopsies | ||
520 | |a RESULTS: Statin therapy was significantly associated with lower EAT thickness (p < 0.0001) and with lower levels of EAT-secreted inflammatory mediators (p < 0.0001). Of note, there was a significant correlation between EAT thickness and its pro-inflammatory status. In vitro, atorvastatin showed a direct anti-inflammatory effect on EAT which was significantly higher compared to the SCAT response to statin incubation (p < 0.0001) | ||
520 | |a CONCLUSIONS: The present study indicates a robust association between statin therapy and reduced EAT accumulation in patients with AS. The present data also suggest a direct relationship between EAT thickness and its inflammatory status, both modulated by statin therapy. The in vitro results support the hypothesis of a direct action of statins on EAT secretory profile. Overall our data suggest EAT as a potential new therapeutic target for statin therapy | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Multicenter Study | |
650 | 4 | |a Aortic stenosis | |
650 | 4 | |a Epicardial adipose tissue | |
650 | 4 | |a Inflammation | |
650 | 4 | |a Statin | |
650 | 7 | |a Cytokines |2 NLM | |
650 | 7 | |a Hydroxymethylglutaryl-CoA Reductase Inhibitors |2 NLM | |
650 | 7 | |a Atorvastatin |2 NLM | |
650 | 7 | |a A0JWA85V8F |2 NLM | |
700 | 1 | |a Petraglia, Laura |e verfasserin |4 aut | |
700 | 1 | |a D'Esposito, Vittoria |e verfasserin |4 aut | |
700 | 1 | |a Cabaro, Serena |e verfasserin |4 aut | |
700 | 1 | |a Rengo, Giuseppe |e verfasserin |4 aut | |
700 | 1 | |a Caruso, Aurelio |e verfasserin |4 aut | |
700 | 1 | |a Grimaldi, Maria Gabriella |e verfasserin |4 aut | |
700 | 1 | |a Baldascino, Francesco |e verfasserin |4 aut | |
700 | 1 | |a De Bellis, Antonio |e verfasserin |4 aut | |
700 | 1 | |a Vitale, Dino |e verfasserin |4 aut | |
700 | 1 | |a Formisano, Roberto |e verfasserin |4 aut | |
700 | 1 | |a Ferro, Adele |e verfasserin |4 aut | |
700 | 1 | |a Paolillo, Stefania |e verfasserin |4 aut | |
700 | 1 | |a Davin, Laurent |e verfasserin |4 aut | |
700 | 1 | |a Lancellotti, Patrizio |e verfasserin |4 aut | |
700 | 1 | |a Formisano, Pietro |e verfasserin |4 aut | |
700 | 1 | |a Perrone Filardi, Pasquale |e verfasserin |4 aut | |
700 | 1 | |a Ferrara, Nicola |e verfasserin |4 aut | |
700 | 1 | |a Leosco, Dario |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International journal of cardiology |d 1984 |g 274(2019) vom: 01. Jan., Seite 326-330 |w (DE-627)NLM012621196 |x 1874-1754 |7 nnns |
773 | 1 | 8 | |g volume:274 |g year:2019 |g day:01 |g month:01 |g pages:326-330 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ijcard.2018.06.106 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 274 |j 2019 |b 01 |c 01 |h 326-330 |